Great-West Lifeco Inc. received a couple positive analyst updates, reinforcing a constructive outlook on the the company’s stock outlook. CIBC World Markets raised its 12 month target price to $73.00 from $67.00 and maintained an Outperform rating, reflecting improving earnings visibility, disciplined capital deployment, and resilient fundamentals across the company’s insurance, wealth management, and retirement platforms. The higher target reflects confidence in Great-West Lifeco’s ability to generate steady cash flows, support dividend growth, and benefit from favorable demographic trends and higher interest rates that enhance investment income.
Barclays Capital also increased their 12 month target price to $70.00 from $59.00, underscoring a re-valuation of the company’s outlook and earnings durability. Barclays’ move reflects growing confidence in management execution, balance sheet strength, and the sustainability of returns across Great-West’s core markets in Canada, the U.S., and Europe. Together, the valuation increase signals strengthening analyst conviction that Great-West Lifeco is well positioned to deliver attractive risk-adjusted returns relative to peers.
